TABLE 4.
Parameter | Total no. of isolates | No. of isolates with katG 315 mutationa:
|
P for katG 315 | No. of isolates with inhA −15 mutation:
|
P for inhA −15 | ||
---|---|---|---|---|---|---|---|
ACC | Other | T | C | ||||
Resistance profile | |||||||
Isoniazid monoresistant | 85 | 51 | 33 | 0.82 | 20 | 65 | 0.88 |
Isoniazid and streptomycin only | 41 | 27 | 14 | 0.42 | 9 | 32 | 0.90 |
MDR M. tuberculosis | 41 | 21 | 19 | 0.43 | 8 | 33 | 0.79 |
Other | 2 | 0 | 2 | 1 | 1 | ||
History of TB | |||||||
No | 89 | 53 | 36 | 0.33 | 21 | 68 | 0.39 |
Yes | 26 | 11 | 13 | 4 | 22 | ||
Unknown | 54 | 35 | 19 | 13 | 41 | ||
Total | 169 | 99 | 68 | 38 | 131 |
For two isolates, katG 315 could not be characterized; the locus could not be amplified due to a probable gene deletion.